Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07493720 · ClinicalTrials.gov registry record
Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood
A clinical trial, sponsored by University of Nebraska.
- Not yet
- Registry status
- 40
- Enrollment target
NCT07493720: Clinical Trial study, sponsored by University of Nebraska.
NCT07493720 is a clinical trial that has not yet begun recruiting, run by University of Nebraska. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07493720 has not yet begun recruiting, sponsored by University of Nebraska.
- NOT YET RECRUITING
- Registry status
- 40 participants
- Enrollment target
Study Summary
The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
Primary Outcome
Venipuncture and peripheral finger stick serum will be tested for beta-hCG levels.
Interventions
- DIAGNOSTIC_TEST Beta-hCG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-12 |
What is known before NCT07493720 opens enrollment
NCT07493720 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Beta-hCG is the first listed.
NCT07493720 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07493720 about?
NCT07493720 is a clinical study titled "Comparison of Beta-hCG Levels When Using Venous Puncture Blood and Peripheral Finger Stick Blood". The objective of his study is to quantitatively evaluate a patient's pregnancy status using their beta-hCG levels when using venipuncture blood vs peripheral blood.
What is the current status of trial NCT07493720?
This trial is currently not yet recruiting. The enrollment target is 40 participants. The study started on 2026-07. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07493720?
The interventions under investigation include: Beta-hCG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07493720?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia